Host: The Japanese Society of Toxicology
In 2035, in vitro culture systems and analytical systems such as AI will be the important items to solve several problems in safety assessment.
This time, I would like to take up MPS, which is attracting global attention both technically and regulatory. Also, I would like to touch on the activity of the AMED-MPS project which is the national project of MPS for drug discovery.
For MPS to be implemented and established as a practical method for safety assessment by 2035, I will introduce each issue in the industry, government, and academia and the efforts for it.
